Is Zentalis PharmaceuticalsL Stock a Good Investment?
Zentalis PharmaceuticalsL Investment Advice | ZNTL |
- Examine Zentalis PharmaceuticalsL's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zentalis PharmaceuticalsL's leadership team and their track record. Good management can help Zentalis PharmaceuticalsL navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Zentalis PharmaceuticalsL's business and its evolving consumer preferences.
- Compare Zentalis PharmaceuticalsL's performance and market position to its competitors. Analyze how Zentalis PharmaceuticalsL is positioned in terms of product offerings, innovation, and market share.
- Check if Zentalis PharmaceuticalsL pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zentalis PharmaceuticalsL's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zentalis PharmaceuticalsLlc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zentalis PharmaceuticalsLlc is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Zentalis PharmaceuticalsL Stock
Researching Zentalis PharmaceuticalsL's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 96.0% of the company outstanding shares are owned by institutional investors. The book value of Zentalis PharmaceuticalsL was at this time reported as 6.18. The company recorded a loss per share of 4.47. Zentalis PharmaceuticalsL had not issued any dividends in recent years.
To determine if Zentalis PharmaceuticalsL is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zentalis PharmaceuticalsL's research are outlined below:
| Zentalis PharmaceuticalsL had very high historical volatility over the last 90 days | |
| Net Loss for the year was (292.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zentalis PharmaceuticalsLlc currently holds about 455.22 M in cash with (207.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.99. | |
| Over 96.0% of the company outstanding shares are owned by institutional investors |
Zentalis PharmaceuticalsL uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zentalis PharmaceuticalsLlc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zentalis PharmaceuticalsL's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Zentalis PharmaceuticalsL's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 831.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zentalis PharmaceuticalsL's market, we take the total number of its shares issued and multiply it by Zentalis PharmaceuticalsL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Basic technical analysis of Zentalis Stock
As of the 7th of May, Zentalis PharmaceuticalsL maintains the Market Risk Adjusted Performance of 2.95, mean deviation of 3.45, and Downside Deviation of 4.79. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zentalis PharmaceuticalsLlc, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Zentalis PharmaceuticalsL, which can be compared to its peers. Please check out Zentalis PharmaceuticalsL information ratio and downside variance to decide if Zentalis PharmaceuticalsL is priced fairly, providing market reflects its latest price of 11.72 per share. Given that Zentalis PharmaceuticalsLlc has jensen alpha of 0.1433, we strongly advise you to confirm Zentalis PharmaceuticalsL's prevalent market performance to make sure the company can sustain itself at a future point.Zentalis PharmaceuticalsL's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zentalis PharmaceuticalsL insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zentalis PharmaceuticalsL's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zentalis PharmaceuticalsL insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vultaggio Vincent over a month ago Disposition of 25000 shares by Vultaggio Vincent of Zentalis PharmaceuticalsL at 11.69 subject to Rule 16b-3 |
Understand Zentalis PharmaceuticalsL's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Zentalis PharmaceuticalsL's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0305 | |||
| Market Risk Adjusted Performance | 2.95 | |||
| Mean Deviation | 3.45 | |||
| Semi Deviation | 4.31 | |||
| Downside Deviation | 4.79 | |||
| Coefficient Of Variation | 2849.72 | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | 0.0182 | |||
| Jensen Alpha | 0.1433 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.017 | |||
| Treynor Ratio | 2.94 | |||
| Maximum Drawdown | 20.88 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 7.66 | |||
| Downside Variance | 22.94 | |||
| Semi Variance | 18.61 | |||
| Expected Short fall | (3.66) | |||
| Skewness | (0.21) | |||
| Kurtosis | (0.01) |
| Risk Adjusted Performance | 0.0305 | |||
| Market Risk Adjusted Performance | 2.95 | |||
| Mean Deviation | 3.45 | |||
| Semi Deviation | 4.31 | |||
| Downside Deviation | 4.79 | |||
| Coefficient Of Variation | 2849.72 | |||
| Standard Deviation | 4.46 | |||
| Variance | 19.9 | |||
| Information Ratio | 0.0182 | |||
| Jensen Alpha | 0.1433 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.017 | |||
| Treynor Ratio | 2.94 | |||
| Maximum Drawdown | 20.88 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 7.66 | |||
| Downside Variance | 22.94 | |||
| Semi Variance | 18.61 | |||
| Expected Short fall | (3.66) | |||
| Skewness | (0.21) | |||
| Kurtosis | (0.01) |
Consider Zentalis PharmaceuticalsL's intraday indicators
Zentalis PharmaceuticalsL intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zentalis PharmaceuticalsL stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Zentalis PharmaceuticalsL time-series forecasting models is one of many Zentalis PharmaceuticalsL's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zentalis PharmaceuticalsL's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Zentalis Stock media impact
Far too much social signal, news, headlines, and media speculation about Zentalis PharmaceuticalsL that are available to investors today. That information is available publicly through Zentalis media outlets and privately through word of mouth or via Zentalis internal channels. However, regardless of the origin, that massive amount of Zentalis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Zentalis PharmaceuticalsL news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zentalis PharmaceuticalsL relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zentalis PharmaceuticalsL's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zentalis PharmaceuticalsL alpha.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Zentalis PharmaceuticalsL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Zentalis PharmaceuticalsL Corporate Management
Elected by the shareholders, the Zentalis PharmaceuticalsL's board of directors comprises two types of representatives: Zentalis PharmaceuticalsL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zentalis. The board's role is to monitor Zentalis PharmaceuticalsL's management team and ensure that shareholders' interests are well served. Zentalis PharmaceuticalsL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zentalis PharmaceuticalsL's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Bunker | CoFounder Officer | Profile | |
| Carrie MD | Chief Officer | Profile | |
| Adrian MD | Executive Development | Profile | |
| Mark Lackner | Chief Strategy | Profile | |
| Kimberly Freeman | Chief Officer | Profile | |
| Adam Levy | VP Relations | Profile |
How to buy Zentalis Stock?
To provide specific investment advice or recommendations on Zentalis PharmaceuticalsLlc stock, we recommend investors consider the following general factors when evaluating Zentalis PharmaceuticalsLlc. This will help you to make an informed decision on whether to include Zentalis PharmaceuticalsL in one of your diversified portfolios:- Examine Zentalis PharmaceuticalsL's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zentalis PharmaceuticalsL's leadership team and their track record. Good management can help Zentalis PharmaceuticalsL navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Zentalis PharmaceuticalsL's business and its evolving consumer preferences.
- Compare Zentalis PharmaceuticalsL's performance and market position to its competitors. Analyze how Zentalis PharmaceuticalsL is positioned in terms of product offerings, innovation, and market share.
- Check if Zentalis PharmaceuticalsL pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zentalis PharmaceuticalsL's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zentalis PharmaceuticalsLlc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zentalis PharmaceuticalsLlc is a good investment.
Already Invested in Zentalis PharmaceuticalsLlc?
The danger of trading Zentalis PharmaceuticalsLlc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zentalis PharmaceuticalsL is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zentalis PharmaceuticalsL. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zentalis PharmaceuticalsL is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zentalis PharmaceuticalsL is a strong investment it is important to analyze Zentalis PharmaceuticalsL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zentalis PharmaceuticalsL's future performance. For an informed investment choice regarding Zentalis Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis PharmaceuticalsLlc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Zentalis Stock analysis
When running Zentalis PharmaceuticalsL's price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Zentalis PharmaceuticalsL's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Zentalis PharmaceuticalsL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.